JHP PHARMACEUTICALS, INC. – Trademark Portfolio

Entity Type: 16

JHP PHARMACEUTICALS, INC. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. Currently, 9 trademarks are registered. Notable registered marks include APLISOL, KETALAR, PITOCIN, BREVITAL, and TRIOSTAT. The owner is based in Parsippany, NJ.

1 Upper Pond Road

Building D - 3rd Floor

Parsippany, NJ 07054

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TRIOSTAT
TRIOSTAT
Registered 1991
APLISOL
APLISOL
Registered 1970
KETALAR
KETALAR
Registered 1967
BREVITAL
BREVITAL
Registered 1959
PITOCIN
PITOCIN
Registered 1928
PITRESSIN
PITRESSIN
Registered 1928
ADRENALIN
ADRENALIN
Registered 1905

Trademark Classifications

JHP PHARMACEUTICALS, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (9 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does JHP PHARMACEUTICALS, INC. have?

JHP PHARMACEUTICALS, INC. has 9 U.S. trademarks filed with the USPTO. Of these, 9 registered.

What trademark classes does JHP PHARMACEUTICALS, INC. file in?

JHP PHARMACEUTICALS, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are JHP PHARMACEUTICALS, INC.'s most well-known trademarks?

JHP PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as APLISOL, KETALAR, PITOCIN, BREVITAL, and TRIOSTAT. These are among 9 currently registered trademarks in the portfolio.

What is JHP PHARMACEUTICALS, INC.'s trademark registration success rate?

JHP PHARMACEUTICALS, INC. has a 100% trademark registration rate, with 9 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.